Daren Hermiston
Directeur Général chez Kona Consulting, Inc.
Fortune : - $ au 30/04/2024
Profil
Daren Hermiston is the founder and CEO of Kona Consulting, Inc. which was founded in 2009.
He also held the position of Director at BioVaxys Technology Corp.
from 2020 to 2022.
In addition, he served as a Director at BioVaxys LLC, Independent Director at Baden Resources, Inc., and Independent Director at TUGA Innovations, Inc. Mr. Hermiston obtained an undergraduate degree from Thompson Rivers University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
TUGA INNOVATIONS, INC.
-.--% | 11/01/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Daren Hermiston
Sociétés | Poste | Début |
---|---|---|
Kona Consulting, Inc. | Directeur Général | 01/01/2009 |
Anciens postes connus de Daren Hermiston
Sociétés | Poste | Fin |
---|---|---|
TUGA INNOVATIONS, INC. | Directeur/Membre du Conseil | 02/08/2023 |
BIOVAXYS TECHNOLOGY CORP. | Directeur/Membre du Conseil | 27/05/2022 |
BioVaxys LLC
BioVaxys LLC BiotechnologyHealth Technology BioVaxys LLC is a clinical stage biotechnology company, which engages in the development of immunotherapeutic vaccines for antiviral and individualized cancer therapy. It focuses on multihaptenized autologous vaccine that will initially be developed and marketed for melanoma and ovarian cancer. The company was founded by James Passin, Kenneth Kovan and David Berd and is headquartered in New York, NY. | Directeur/Membre du Conseil | 01/07/2021 |
NORTHSTAR GAMING HOLDINGS INC. | Directeur/Membre du Conseil | - |
Formation de Daren Hermiston
Thompson Rivers University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BIOVAXYS TECHNOLOGY CORP. | Non-Energy Minerals |
Entreprise privées | 4 |
---|---|
BioVaxys LLC
BioVaxys LLC BiotechnologyHealth Technology BioVaxys LLC is a clinical stage biotechnology company, which engages in the development of immunotherapeutic vaccines for antiviral and individualized cancer therapy. It focuses on multihaptenized autologous vaccine that will initially be developed and marketed for melanoma and ovarian cancer. The company was founded by James Passin, Kenneth Kovan and David Berd and is headquartered in New York, NY. | Health Technology |
Baden Resources, Inc.
Baden Resources, Inc. Other Metals/MineralsNon-Energy Minerals Baden Resources, Inc. operates as a mineral exploration and development company. The firm engages in the acquisition and exploration of minerals and development of mining properties. The company was founded by Howard D. Milne and Stephen M. Mathiesen on January 19, 2020 and is headquartered in Vancouver, Canada. | Non-Energy Minerals |
Kona Consulting, Inc. | |
TUGA Innovations, Inc. |